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Abstract
Background: Vitamin D (Vit D) is important for the regulation of reproductive physiology. In humans, maternal Vit
D deficiency has been implicated in several reproductive- and pregnancy-related disorders. Very few data are
available regarding the Vit D status in male partners of couples attempting pregnancy. This observational study (IRB
Prot. N. 078/13) aimed to evaluate whether low Vit D serum levels in males might decrease the rate of successful
conception in couples attempting pregnancy.
Methods: Male and female partners of infertile couples (n = 102) were classified into 2 GROUPS according to
normal (≥30 ng/ml) or low (below 30 ng/ml) serum Vit D levels in male partners. Semen analysis was performed in
each male participant based on the WHO reference criteria. The female partners of both groups were subjected to
3 consecutive cycles of gonadotropin-induced mono-ovulation. The main outcome measures included the clinical
pregnancy rate, delivery per patient and per cycle, and miscarriage rate between the 2 groups evaluated at the end
of the three-month period of the study.
Results: In male partners of both groups, standard semen analysis did not highlight substantial differences in
sperm concentration, sperm progressive motility, or typical form. The pregnancy rates per patient and per cycle and
delivery rates per patient and per cycle were all significantly higher (p< 0.05) in couples with normal Vit D levels.
Conclusions: These results suggest the existence of a relationship between male Vit D serum levels and semen
ability to begin a pregnancy during cycles of timed vaginal intercourse.
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Background
The steroid hormone 25-hydroxycholecalciferol (Vita-
min D (25(OH)D; Vit D)) has been recognized for its
relevance to bone health and calcium homeostasis. In re-
cent years, a number of experimental, observational and
interventional studies have acknowledged the preventa-
tive role played by Vit D in physiological non-skeletal
functions [1, 2]. Vit D deficiency (25(OH)D: <20 ng/mL)
and insufficiency (25(OH)D: 20–29 ng/mL) are associ-
ated with skeletal diseases such as rickets, osteomalacia,
osteoporosis and with chronic illnesses including auto-
immune diseases such as multiple sclerosis or type 1 dia-
betes, inflammatory bowel disease such as Crohn’s
disease, infections, especially of the upper respiratory
tract, cardiovascular disturbances including hyperten-
sion, coronary artery disease, and heart failure, cancer
such as colon and breast cancer, or non-Hodgkin’s
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lymphoma, and neurocognitive disorders, such as Alz-
heimer disease [3–6].
In addition to genetic predisposition [7], Vit D defi-
ciency often results from inadequate dietary intake or in-
sufficient cutaneous production [8]. In humans, the
predominant source of Vit D is represented by the en-
dogenous cutaneous synthesis, and dietary sources con-
tribute to less than 20 % of the circulating levels of Vit
D [9]. In the dermal fibroblasts and epidermal keratino-
cytes, the endogenous synthesis of Vit D occurs after
photolytic conversion of 7-dehydrocholesterol (7(OH)D)
by the ultraviolet B component of sunlight [10]. Subse-
quently, 7(OH)D is hydroxylated to 25(OH)D3 in the
liver and is finally transformed to the active form of the
vitamin, 1,25-dihydroxyvitamin D (1,25(OH)2D), in the
kidney and in other target tissues [11, 12]. Active
1,25(OH)2D exerts genomic and non-genomic actions
via its cognate nuclear receptors [13]. Typically, in sub-
jects exposed to upwards of 300 h of sunshine per
month, serum levels of 25(OH)D increase to the range
of 35 ng/mL [14]. However, because the half-life of
25(OH)D is approximately 2–3 weeks [15], serum levels
decline below the desired values of 30 ng/mL within 1–2
months when sunlight could no longer produce any vita-
min D in the skin. This decline might be particularly
relevant in the North European population. An ongoing
clinical trial is evaluating the effects of Vit D supplemen-
tation in infertile Danish men [16]. In addition to lati-
tude, several other factors including environmental
pollution and increasing concerns about the carcino-
genic potential of sunlight and subsequent increased use
of sunscreen are recognized contributors to Vit D insuf-
ficiency [17], which has become a worldwide health issue
[18–20]. Thus, even in a Mediterranean country, levels
of Vit D might frequently decline below desired levels,
especially during the winter [21].
The regulatory role of Vit D in reproductive physi-
ology is highlighted by the expression of vitamin D re-
ceptors (VDR) and enzymes that metabolize Vit D in the
ovary, uterus, and placenta and in the testis, male repro-
ductive tract and human spermatozoa [22, 23]. The
phenotype of the Tokio strain of mice with a disrupted
VDR binding domain (Vdr−/−) is characterized by se-
verely impaired fertility and histological abnormalities of
the gonads from both sexes [24]. The importance of Vit
D for male reproduction has been demonstrated in ro-
dents by studies reporting that Vit D deficiency leads to
reduced sperm counts, impaired sperm motility and
lower fertility rates in females inseminated with semen
from Vit D deficient males [25, 26]. In humans, the VDR
and all the Vit D metabolizing enzymes are co-expressed
during the late stages of spermatogenesis in the neck of
mature spermatozoa [27]. It is likely that optimal sperm
function might be influenced by Vit D directly or
indirectly through Vit D-related calcium homeostasis
[28]. Although a role for calcium in the maturation of
human spermatozoa is supported by the 2–3-fold higher
calcium concentration in the epididymal and prostate
fluid compared with serum [29], the precise effects of
Vit D on human sperm motility and vitality remains un-
clear. Based on the observations outlined above, it is
plausible that Vit D deficiency might worsen the quality
of sperm and significantly reduce its fertilizing capacity.
The Vit D status in humans is measured by serum levels
of 25(OH)D, and serum values below 30 ng/ml indicate
Vit D insufficiency [30, 31].
This observational, pilot study was planned to evaluate
whether Vit D levels might play a role on reproductive
outcomes and whether low Vit D serum levels in males
living in a Mediterranean country might decrease the
rate of successful conception in couples attempting
pregnancy.
Methods
All procedures were in accordance with the Helsinki
Declaration on Human Experimentation and were ap-
proved by the local Institutional Review Board (IRB)
(Prot. N 078/13). One hundred and two (102) young
couples reporting at least 1 year of sexual intercourse
without the use of any contraceptive method were se-
lected for the study between January 2014 and October
2014; all couples were accessing our academically affili-
ated private infertility center. Each eligible participant
received a detailed explanation regarding the significance
of an observational study evaluating the role of low/in-
sufficient levels of Vit D in male partners on the rate of
successful pregnancy. The subjects consenting to be en-
rolled and fulfilling the inclusion criteria were asked to
sign a written informed consent. The study was carried
out from November 2014 to January 2015.
In women, the ages ranged from 23 to 35 years (29.7
± 2.6 years) and the infertility period ranged from 12 to
36 months (28.8 ± 3.5 months). All female patients had
normal glucose tolerance according to the American
Diabetes Association recommendations [32] and normal
markers of thyroid, liver, and kidney function; none of
the subjects were observing a specific diet or had been
taking oral contraceptives or other long-term drugs in
the 6 months preceding the beginning of the study. In
all women, the endocrine profile was normal, according
to values of the following hormones measured on day 3
of the cycle: for follicle-stimulating hormone (FSH) and
luteinizing hormone (LH), the serum levels were <10
mUI/ml; prolactin levels were <15 ng/mL, and testoster-
one levels were <0.6 ng/mL. In all cases, progesterone
(P) levels in the mid-luteal phase were higher than 6 ng/
mL. All women had appropriate late luteal phase endo-
metrial biopsies, normal cervical mucus, and bilateral
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tubal patency. The body mass index (weight/height2,
expressed as kg/m2), plasma estrogen levels, and follicle
diameter were recorded on day of human chorionic go-
nadotropin (hCG) administration. All hormone determi-
nations were performed with appropriate commercial
kits (Diagnostic System Laboratories Inc, Webster, Tex);
intra-assay and inter-assay coefficients of variation were
less than 10 %.
Serum Vit D levels were assessed in men and women
by measuring serum 25(OH)D levels by a chemilumines-
cence immunoassay (Liaison Assay; Diasorin; Se: 4;
CV%: 4.8 %–5.5 %). This assay accurately quantifies the
sum of 25(OH)D3 and 25(OH)D2. Female patients
whose Vit D levels were considered in the range of in-
sufficiency (25(OH)D: 20–29 ng/ml) were given exogen-
ous Vit D to obtain values higher than 30 ng/ml before
the beginning of study, and their Vit D values were
maintained in the control range throughout the study.
Couples enrolled in this study were classified into 2
groups according to the Vit D values of the male part-
ners. The male partners in couples of GROUP 1 - Nor-
mal VD (n = 39) had normal Vit D levels (≥30 ng/ml);
the male partners in couples of GROUP 2 – Low VD
(n = 63) had Vit D levels below 30 ng/ml. Couples were
excluded if either the male or female partners were sub-
jected to treatments interfering with Vit D metabolism.
The male participants from both groups were advised
not to change their diets during the period of the study.
Men with diabetes mellitus, thyroid disease, or inflam-
matory bowel disease were not included in the study.
Among the male partner participants, seminal plasma
from the ejaculate was obtained by voluntary masturba-
tion after 3 days of sexual abstinence. Samples collected
into a sterile container were allowed to liquefy for
30 min at room temperature before being analyzed ac-
cording to standard World Health Organization (WHO)
protocols [33, 34]. Standard semen analysis was per-
formed by two experienced technicians operating under
an active quality control program.
In both groups, the female partners were subjected to 3
consecutive cycles of gonadotropin-induced mono-
ovulation under ultrasound monitoring, followed by
follicular-timed vaginal intercourse. Three consecutive cy-
cles of treatment were evaluated to prevent carryover ef-
fects of repeated ovarian stimulations [35]. Ovarian
stimulation was performed with recombinant FSH
(hrFSH, follitropin beta; Puregon, NV Organon, Oss, The
Netherlands) starting at a daily dose of 50–100 IU on the
third day of the cycle. Transvaginal ultrasound examina-
tions were repeated every other day from the 5th day of
treatment until the mean diameter of the dominant follicle
measured 14 mm; thereafter, transvaginal ultrasounds
were performed daily. Human chorionic gonadotropin
(hCG; 10.000 IU; Gonasi IBSA, Rome, Italy) was
administered when the mean diameter of the follicles
reached 18 mm. Vaginal intercourse was suggested during
the 30–36 h following hCG administration.
Main outcome measures
The main outcome measures included the clinical preg-
nancy rate, delivery per patient and per cycle, and mis-
carriage rate between the 2 groups evaluated at the end
of the three month period of the study. For the purpose
of this study, the overall number of clinical pregnancies
was calculated. Clinical pregnancy was defined as the
presence of either an embryonic heart beat on transvagi-
nal ultrasonography or the presence of a trophoblast at
histologic evaluation after spontaneous abortion.
Statistical analysis
Data were analyzed using Statistica software from Stat-
Soft (Tulsa, Oklahoma, USA). Differences in baseline
characteristics, clinical pregnancy rate, delivery per pa-
tient and per cycle, and miscarriage rate between the 2
groups were evaluated with Pearson’s χ2 test with Yates’
continuity correction and Fisher’s exact test. The results
are expressed as the mean ± standard deviation (SD) un-
less otherwise specified. A value of P < 0.05 was consid-
ered to indicate statistical significance.
Results
The 102 couples enrolled in this study were classified
into 2 groups according to serum Vit D levels in male
partners; 39 couples were assigned to GROUP 1 – Nor-
mal Vit D (≥30 ng/ml), and 63 couples were assigned to
GROUP 2 – Low Vit D (<30 ng/ml). During the three
month period of the study, 12 couples (3 in GROUP 1
and 9 in GROUP 2) failed to complete the 3 consecutive
cycles of treatment and were excluded from the study.
In total, 90 out of 102 couples (36 in GROUP 1 and 54
in GROUP 2) completed the study.
There were no substantial differences in the physio-
logical parameters or biochemical markers of the male
partners from the two groups (Table 1). Although the
serum Vit D levels were significantly lower in the male
Table 1 Characteristics of male partners in the 2 groups
GROUP 1 GROUP 2 P
ValueNormal Vit D Low Vit D
Age (years) 34.1 ± 3.8 36.5 ± 1.4 n.s.
Body mass index (kg/m2) 24.6 ± 2.5 23.8 ± 2.7 n.s.
Systolic Blood Pressure (mmHg) 125.8 ± 11.3 121.2 ± 9.2 n.s.
Blood glucose (mg/dl) 101.7 ± 7.1 98.8 ± 10.7 n.s.
Serum PSA (ng/mL)a 2.6 ± 0.5 2.1 ± 0.6 n.s.
Smoking (n/tot) 12/36 17/54 n.s.
Values are mean ± SD
aPSA prostate specific antigen
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patients of GROUP 2 compared with GROUP 1 (P <
0.001), no substantial difference was observed in the
sperm concentration, sperm progressive motility, or typ-
ical form percent in samples from the subjects of
GROUP 1 compared with subjects of GROUP 2
(Table 2).
The main characteristics of the female partners in
GROUP 1 and GROUP 2 are summarized in Table 3.
The age, duration of infertility, BMI, plasma estrogen
level, and follicle diameter on hCG day of administration
were similar in women from both groups. Among the 90
couples recruited, 108 cycles of timed vaginal inter-
course were performed in GROUP 1, and 162 cycles
were performed in GROUP 2. Differences in clinical
pregnancies, pregnancy rates per patient and per cycle,
delivery rates per patient and per cycle, numbers of mis-
carriages and miscarriage rates are reported in Table 4.
All parameters evaluating pregnancy and delivery were
significantly higher in couples with normal serum levels
of Vit D (GROUP 1) than in couples with low Vit D
levels (GROUP 2). A tendency towards a higher rate of
miscarriage was observed in subjects of GROUP 2; al-
though the miscarriage rate was higher in GROUP 2
than in GROUP 1, this parameter did not reach statis-
tical significance (p> 0.23). No hyperstimulation or ec-
topic pregnancies occurred in either group.
Discussion
Human infertility is defined as the failure to achieve a
clinical pregnancy after twelve months of regular,
contraceptive-free sexual intercourse [36]. All couples
recruited in this study did not attain pregnancy despite
the lack of use of any contraceptive method during the
last year of sexual intercourse. Twelve months is the
lower reference limit for Time To Pregnancy (TTP), and
TTP is a good indicator of fertility potential because it
depends on regular ovulation, oocyte quality, and semen
quality variables [37].
To our knowledge, this is the first study evaluating the
correlation between serum Vit D levels in men and preg-
nancy rates in their female partners undergoing mono-
ovulation induction and timed intercourse. The existing
literature supports a solid role of Vit D for the regula-
tion of reproductive physiology in male and female
animal models [23, 38]. In humans, maternal Vit D defi-
ciency has been implicated in several reproductive- and
pregnancy-related disorders, ranging from PCOS to pre-
mature birth [39, 40]. Very few data are available regard-
ing the Vit D status in male partners of couples
attempting pregnancy [41].
To investigate whether male hypovitaminosis D might
be a discriminating factor for successful pregnancy, the
female partners of all couples in this study underwent
identical procedures. The beneficial effects of ovulation
induction in terms of improved oocyte quality, improved
timing of the ovulatory period, and correction of slight
and unknown ovulatory disorders have long been dem-
onstrated [42, 43]. In female partners, we adopted a
stimulation protocol with low doses of gonadotropin to
obtain a cohort of mono-ovulatory patients that was as
homogeneous as possible; in both groups, no cases of
multiple pregnancies or hyperstimulation were observed.
In the women of GROUP 1 and GROUP 2, the Vit D
levels were in the control range (>30 ng/ml) for the dur-
ation of the study. Furthermore, the female patients
assigned to GROUP 1 or GROUP 2 had comparable age
distributions, estrogen plasma levels, numbers of rFSH
Table 2 Standard characteristics of semen in the 2 groupsa
GROUP 1 GROUP 2 P Value
Normal Vit D Low Vit D
Serum Vit. D (ng/ml) 34.2 ± 3.38 18.4 ± 5.82 p < 0.001
Sperm concentration (x 106/mL) 16.9 ± 2.41 16.1 ± 2.40 n.s.
Sperm progressive motility (%) 40.3 ± 2.99 39.7 ± 3.4 n.s.
Typical forms (%) 5.03 ± 0.99 5.11 ± 0.94 n.s.
aValues are mean ± SD
Table 3 Characteristics of female partners in the 2 groupsa
GROUP 1 GROUP 2 P
ValueNormal Vit D Low Vit D
Number of Couples 36 54 n.s.
Age (years) 30.1 ± 2.57 29.5 ± 2.57 n.s.
Duration of infertility (months) 28.5 ± 4.53 29.1 ± 2.57 n.s.
Serum estradiol (pg/mL)b 291.2 ± 31.73 293.1 ± 19.81 n.s.
Follicle diameter (mm) 18.2 ± 1.28 18.0 ± 1.34 n.s.
Body mass index (kg/m2) 20.8 ± 1.14 21.1 ± 1.37 n.s.
aValues are mean ± SD
bOn the day of hCG administration. Conversion factor to SI unit = 3.671
Table 4 Number of total cycles and pregnancy rate per patient
and per cycle in the 2 groupsa
GROUP 1 GROUP 2 P Value
Normal Vit D Low Vit D
No. of couples 36 54 n.s.
No. of cycles 108 162 n.s.
No. of clinical pregnancies 10 5 n.s.
No. of term pregnancies 8 2 n.s.
Pregnancy rate/patient (%) 27.7 9.2 p < 0.05
Pregnancy rate/cycle (%) 9.2 3.0 p < 0.05
Delivery rate/patient (%) 22.2 3.7 p < 0.02
Delivery rate/cycle (%) 7.4 1.2 p < 0.01
No. of miscarriage 2 3 n.s.
Miscarriage rate (%) 20 60 n.s.
a Values are mean ± SD
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ampoules used, and days of therapy (data not shown).
Therefore, it is reasonable to presume that the oocytes
in the women of the two groups were of comparable
quality.
In the male partners of GROUP 1 and GROUP 2,
standard semen analysis did not highlight substantial dif-
ferences in sperm concentration, sperm progressive mo-
tility, or typical form. This observation might have
several explanations. First, routine semen analysis itself
has its own limitations, and does not account for puta-
tive sperm dysfunctions such as immature chromatin or
fragmented DNA. In addition, semen components might
be influenced by several other factors, such as sexual ac-
tivity and accessory sex gland function. If anything, this
finding confirms the poor predictive significance of
semen analysis in terms of fertility potential.
Because the pregnancy rates per patient and per cycle
were appreciably higher in couples of GROUP 1 (male
partners with normal Vit D serum levels), the assump-
tion that the worse prognosis of successful pregnancy is
in couples whose male partners have low Vit D levels
appears clear.
The results obtained in this study are in agreement
with data supporting the relevance of Vit D in the
regulation of male reproductive physiology. For ex-
ample, the VDR has been shown to be present in the
hypothalamic–pituitary axis, the testis and on the
head/nucleus of the sperm and mid-piece [23, 44]. Al-
though the exact role of the VDR in the sperm nu-
cleus is unclear, it has been suggested to acts as a
protective genomic factor because it is important for
the proper control of sperm DNA integrity and the
maintenance of genome stability [22].
Enzymes responsible for active Vit D conversion have
been found in male reproductive tissues, and locally pro-
duced Vit D appears to modulate cholesterol efflux in
human sperm, affect tyrosine and threonine phosphoryl-
ation of sperm proteins and increase sperm viability
[45]. By increasing intracellular calcium concentrations,
sperm motility and acrosin activity within the female re-
productive tract, tissue-specific production of Vit D
might significantly contribute to overall fertilizing cap-
acity. The increased embryonic loss observed in couples
whose male partners had low serum Vit D levels is con-
sistent with this hypothesis.
Some limitations should be taken into account when
considering the results. First, the small sample size of
this observational, pilot study might not accurately ad-
dress the contributions of other potential confounding
factors to involuntary male infertility. However, the
physiological and biochemical parameters related to the
most well-known variables involved in male fertility
(BMI, blood pressure, smoking habits, blood glucose
profile) did not differ between the men of the two
groups. Second, this study was carried out during the win-
ter months, when Vit D levels are known to be the lowest.
This period was purposely selected to stress the potential
relevance of male Vit D insufficiency to fertilizing capacity
in a Mediterranean population. Nevertheless, seasonal dif-
ferences might be relevant to serum levels of Vit D, and
this aspect should be adequately considered in further
studies. Third, our study does not directly address the spe-
cific mechanisms by which Vit D is involved in
reproduction, although some hypotheses could be sug-
gested. For example, it is possible that insufficient Vit D
levels in males might decrease protection from inflamma-
tory signaling and oxidative stress in spermatozoa, as
demonstrated in several other cell types [46–48]. This in-
sufficiency might affect the functional integrity of the
spermatozoa, therefore reducing sperm fertility potential
by causing implantation disorders, rather than fertilization
problems. Supernumerary defective spermatozoa could
damage the oocyte or pro-nucleate embryo by altering the
physical-chemical properties of the zona pellucida via the
release of toxic metabolites such as oxygen radicals [49].
Subtle abnormalities in defective Vit D spermatozoa might
lead to subsequent abnormal membrane function in the
embryo and anomalies in the cell-to-cell communication/
binding that appear to have an important role in the at-
tachment of the blastocyst and penetration of surface epi-
thelium of the endometrium [50]. Further support for this
hypothesis comes from human studies indicating that pa-
ternally derived proteins are expressed in the embryo at
the pre-implantation stage [51]. An additional mechanism
that might help explain the relationship between sperm
abnormalities and poor pregnancy outcomes is a
desynchronization between slower embryonic develop-
ment and the uterine environment [52]. According to this
view, it is plausible that defective spermatozoa could lead
to a less viable embryo, and therefore to a low viable preg-
nancy rate with a high miscarriage rate. Consistent with
this hypothesis, a tendency towards a higher rate of mis-
carriage was observed in the couples of GROUP 2 in our
study.
Conclusions
Taken together, the results from our pilot study suggest the
existence of a direct relationship between male Vit D serum
levels and semen ability to begin a pregnancy during cycles
of timed vaginal intercourse. Further studies are required to
elucidate the pathophysiology of this condition and its rela-
tionship to overall male fertility. Given its recognized safety,
accessibility and ease of administration, the evaluation of
Vit D levels and subsequent Vit D supplementation in male
individuals with serum levels below the normal range could
represent a cost effective strategy to improve the chances of
clinical pregnancy for couples undergoing mono-ovulation
induction and timed intercourse.
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